Name
Perearst Ladva osaühing
Registry code
10763963
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.05.2001 (23)
Financial year
01.01-31.12
Capital
3 196.00 €
Activity
86211 - Provision of general medical treatment
0 €
-20 872 €
-
-
419 564 €
0
Submitted
No tax arrears
-5%
-5%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Anne Ladva 02.08.1955 (69) | 100% - 3 196.00 EUR | Board member | Direct ownership | Founder |
| Kalev Ladva 18.03.1953 (71) | - | Board member | Other control or influence (contractual, family or other relationships) | Founder |
| 2019 30.06.2020 | 2020 02.06.2021 | 2021 17.05.2022 | 2022 16.05.2023 | 2023 05.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 371 050 € | 465 505 € | 533 545 € | 297 307 € | 0 € |
| Net profit (loss) for the period | 37 019 € | 100 921 € | 106 558 € | 13 167 € | -20 872 € |
| Profit Margin | 10% | 22% | 20% | 4% | - |
| Current Assets | 229 798 € | 338 380 € | 458 915 € | 411 314 € | 406 081 € |
| Fixed Assets | 18 074 € | 17 480 € | 8 596 € | 30 830 € | 15 190 € |
| Total Assets | 247 872 € | 355 860 € | 467 511 € | 442 144 € | 421 271 € |
| Current Liabilities | 28 102 € | 35 148 € | 40 241 € | 1 707 € | 1 707 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 219 770 € | 320 712 € | 427 270 € | 440 437 € | 419 564 € |
| Employees | 7 | 7 | 7 | 7 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 545.62 € | 339.57 € | - |
| 2023 Q4 | - | 545.37 € | 339.57 € | - |
| 2023 Q3 | - | 545.37 € | 339.57 € | - |
| 2023 Q2 | - | 545.62 € | 339.57 € | - |
| 2023 Q1 | - | 545.37 € | 339.57 € | - |
| 2022 Q4 | - | 851.81 € | 530.37 € | - |
| 2022 Q3 | - | 26 790.11 € | 27 529.68 € | - |
| 2022 Q2 | - | 32 229.66 € | 33 448.18 € | 11 |
| 2022 Q1 | - | 29 582.25 € | 30 653.71 € | 10 |
| 2021 Q4 | - | 28 647.17 € | 29 590.02 € | 9 |
| 2021 Q3 | - | 33 081.8 € | 34 320.49 € | 9 |
| 2021 Q2 | - | 23 600.53 € | 24 385.5 € | 9 |
| 2021 Q1 | - | 24 800.8 € | 25 572.21 € | 9 |
| 2020 Q4 | - | 25 936.06 € | 26 656.2 € | 11 |
| 2020 Q3 | - | 22 615.57 € | 23 336.01 € | 10 |
| 2020 Q2 | - | 18 415.65 € | 18 934.85 € | 10 |
| 2020 Q1 | - | 22 104.4 € | 22 822.17 € | 10 |
